Skip to main content

Table 2 The baseline infection intensity and curative status of respondents

From: In vivo and in vitro efficacy of a single dose of albendazole against hookworm infection in northwest Ethiopia: open-label trial

Infection intensity during baseline

Curative status of respondents

Total

Cure

Non-cure

Count

Percent

Count

Percent

Low

35

94.6%

2

5.4%

37/100%

Moderate

23

88.5%

3

11.5%

26/100%

Heavy

3

43%

4

57%

7/100%

Total

61

87%

9

13%

70/100%